📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: LigoCyte Pharmaceuticals

1.1 - Company Overview

LigoCyte Pharmaceuticals Logo

LigoCyte Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of vaccines and monoclonal antibodies for gastrointestinal and respiratory indications, developing novel immunomodulatory drug compounds that modify immune responses by targeting cell binding interactions for the treatment of inflammatory and infectious diseases.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to LigoCyte Pharmaceuticals

Okairos Logo

Okairos

HQ: Switzerland Website
  • Description: Provider of biopharmaceutical discovery and development of genetic T-cell vaccines, including for hepatitis C virus, and health and allied services. Based in Basel, Switzerland, with operations in Rome and Naples, Italy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Okairos company profile →
Cempra Logo

Cempra

HQ: United States Website
  • Description: Provider of medicines for the treatment of bacterial infections and chronic illnesses.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cempra company profile →
Melinta Logo

Melinta

HQ: United States Website
  • Description: Provider of antibiotics, developing and commercializing antibiotics to overcome drug-resistant infections.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Melinta company profile →
Spectral Medical Logo

Spectral Medical

HQ: Canada Website
  • Description: Provider of therapies and diagnostics for septic shock and sepsis risk, including Toraymyxin (PMX) hemoperfusion to remove endotoxin and the Endotoxin Activity Assay (EAA). Conducts the Tigris Phase 3 study of PMX with standard care. Also offers the DIMI hemodialysis system for continuous renal replacement therapy, licensed for hospitals, clinics, and homes in Canada and the USA, and the SAMI device for continuous renal replacement therapy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Spectral Medical company profile →
Calimmune Logo

Calimmune

HQ: United States Website
  • Description: Provider of clinical-stage gene therapies, including a lead gene-based therapeutic candidate engineered to control HIV infection and protect individuals with HIV from progressing to AIDS. The therapy is currently being evaluated in Phase I/II studies. Cal-1 is designed to reduce production of CCR5, a protein.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Calimmune company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for LigoCyte Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to LigoCyte Pharmaceuticals

2.2 - Growth funds investing in similar companies to LigoCyte Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for LigoCyte Pharmaceuticals

4.2 - Public trading comparable groups for LigoCyte Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to LigoCyte Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About LigoCyte Pharmaceuticals

What does LigoCyte Pharmaceuticals do?

LigoCyte Pharmaceuticals is a provider of vaccines and monoclonal antibodies for gastrointestinal and respiratory indications, developing novel immunomodulatory drug compounds that modify immune responses by targeting cell binding interactions for the treatment of inflammatory and infectious diseases.

Who are LigoCyte Pharmaceuticals's competitors?

LigoCyte Pharmaceuticals's competitors and similar companies include Okairos, Cempra, Melinta, Spectral Medical, and Calimmune.

Where is LigoCyte Pharmaceuticals headquartered?

LigoCyte Pharmaceuticals is headquartered in United States.

How many employees does LigoCyte Pharmaceuticals have?

LigoCyte Pharmaceuticals has 1,000 employees 🔒.

When was LigoCyte Pharmaceuticals founded?

LigoCyte Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is LigoCyte Pharmaceuticals in?

LigoCyte Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for LigoCyte Pharmaceuticals

Who are the top strategic acquirers in LigoCyte Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in LigoCyte Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for LigoCyte Pharmaceuticals?

Top strategic M&A buyers groups and sectors for LigoCyte Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in LigoCyte Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in LigoCyte Pharmaceuticals's sector and industry vertical?

Top PE firms investing in LigoCyte Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in LigoCyte Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in LigoCyte Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in LigoCyte Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to LigoCyte Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in LigoCyte Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for LigoCyte Pharmaceuticals?

The key public trading comparables and valuation benchmarks for LigoCyte Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for LigoCyte Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for LigoCyte Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in LigoCyte Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for LigoCyte Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in LigoCyte Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in LigoCyte Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for LigoCyte Pharmaceuticals